最近的进展针对乳腺癌的化学因子
Yanan Zhang1, Xiufeng Tang2, Ying Wang1
1College of Biological and Chemical Engineering, Qilu Institute of Technology, Shandong, China.
International immunopharmacology
|December 24, 2024
概括
化基因及其受体在乳腺癌 (BC) 的发展和免疫反应中至关重要. 了解它们的作用为BC治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 乳腺癌 (BC) 是一种由分子相互作用驱动的复杂疾病.
- 化基因及其受体在细胞迁移和免疫调节中至关重要,影响BC.
- 它们在BC病理生理学中的作用,包括增殖,迁移,入侵和血管生成,是显著的.
研究的目的:
- 审查BC.中的化学因子和受体的分类,功能和机制.
- 探索它们在BC免疫微环境和免疫细胞行为中的调节作用.
- 总结目前的BC治疗策略,涉及化基因和受体,并建议未来的研究方向.
主要方法:
- 文献综述和综合现有关于乳腺癌中化学因子和受体的研究.
- 对基因基因和受体参与BC细胞行为的分子机制的分析.
- 检查化基因和受体对免疫细胞透,偏振和抗瘤反应的影响.
主要成果:
- 化基因和受体显著调节BC细胞的增殖,迁移,入侵和血管生成.
- 这些分子极大地塑造了BC免疫微环境,影响了免疫细胞的透和两极分化.
- 化基因和受体影响BC.的抗瘤免疫反应的有效性.
结论:
- 准化基因及其受体为新型乳腺癌疗法提供了一个有希望的途径.
- 对这些途径的进一步研究可以提高我们对BC进展和免疫逃避的理解.
- 未来的策略可能涉及调节化学激素受体相互作用,以改善乳腺癌患者的治疗结果.
更多相关视频
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
8.4K
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.3K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotaxis and Direction of Cell Migration
3.3K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cell-surface Signaling
51.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
